Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...

Full description

Saved in:
Bibliographic Details
Main Authors: Alistair Ring (Author), Meghan Karuturi (Author), Emily Nash Smyth (Author), Tasneem Lokhandwala (Author), Kristin M. Sheffield (Author), Joanne Willey (Author), Orsolya Lunacsek (Author), Francisco Sapunar (Author), Zhanglin Lin Cui (Author), Anna D. Coutinho (Author), Sarah Rybowski (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available